<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 30-year-old male with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> underwent pars plana lensectomy and vitrectomy combined with <z:chebi fb="144" ids="48140">silicone</z:chebi> oil injection for the treatment of <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> with <z:e sem="disease" ids="C0242852" disease_type="Disease or Syndrome" abbrv="">proliferative vitreoretinopathy</z:e> (PVR) </plain></SENT>
<SENT sid="1" pm="."><plain>Four months after vitrectomy, the <z:chebi fb="144" ids="48140">silicone</z:chebi> oil was removed using an anterior chamber maintainer (AC) and a self-sealing clear corneal incision at the upper temporal quadrant </plain></SENT>
<SENT sid="2" pm="."><plain>Suprachoroidal <z:mp ids='MP_0001914'>hemorrhage</z:mp> (SCH) developed at the end of the operation </plain></SENT>
<SENT sid="3" pm="."><plain>It was limited to the nasal side of the retina </plain></SENT>
<SENT sid="4" pm="."><plain>Suprachoroidal <z:mp ids='MP_0001914'>hemorrhage</z:mp> remained to be limited and did not show progression </plain></SENT>
</text></document>